NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Great point Dan88. As we know, Dr. Keyoumars was the Principal Investigator for the DCVax-L Phase III trial in the UK & the entire EU. As such, I believe he has seen the unblinded & unblended DCVax-L TLD. I believe he is also helping to write & review the DCVax-L trial results peer-reviewed journal article.

If he did not know first-hand that DCVax-L is very safe & effective for GBM patients, he would not be advocating to treat his patients with it, especially at a cost of £200,000+.

I also believe that Dr. Keyoumars is one of the experts that NWBio has consulted with regarding the path forward, including the timing of publicly releasing TLD & publishing the data in a peer-reviewed medical journal.